The Bangalore-based firm has finally received some recognition with the World Economic Forum (WEF) choosing it as one of the 39 technology pioneers from a list of 273 nominees. Neurosynaptics, the only company from India in a list dominated by 23 US firms, has been picked for its ReMeDi (Remote Medical Diagnostics) range of products.
The government will allocate INR 1,360 billion (USD 34.50 billion) for healthcare in the 11th Five-Year Plan (2007-12), up from INR 450 billion in the previous plan, said Union Health Minister Anbumani Ramadoss. He also said that the government will introduce a ‘health smart card’ under the National School Health Programme for every school-going child.
US-based $23-billion diversified technology firm 3M is in talks with top domestic pharma companies to licence drug delivery technologies.
IBM is targeting multi-billion dollar health business opportunities in India. The company has plans to tap opportunities worth $1 billion each in the Indian pharmaceuticals and health service segments over the next 3-4 years.
In a major blow to chemists charging hefty margins from consumers, the government has decided to limit trade margins on all medicines sold in the country.
ICICI Venture is planning to float a company that will buy medium-sized hospitals and pharmacy chains and act as a holding company for the fund
ICICI Venture is planning to float a company that will buy medium-sized hospitals and pharmacy chains and act as a holding company for the fund
Pfizer, a US-based pharmaceutical giant, is looking to cut costs by outsourcing as much as 30 per cent of its manufacturing to facilities in Asia, particularly in India and China.
IBM is targeting multi-billion dollar health business opportunities in India. The company has plans to tap opportunities worth $1 billion each in the Indian pharmaceuticals and health service segments over the next 3-4 years.
The pharma sector may have underperformed in the Sensex , but companies providing contract research and manufacturing services (CRAMS) to global pharma companies have given good returns.
IBM is targeting multi-billion dollar health business opportunities in India. The company has plans to tap opportunities worth $1 billion each in the Indian pharmaceuticals and health service segments over the next 3-4 years.
In a major blow to chemists charging hefty margins from consumers, the government has decided to limit trade margins on all medicines sold in the country.
[This article was published in the December 2007 issue of the eHEALTH Magazine (https://www.ehealthonline.org)]
News Review
